Abstract
This article, taken from a presentation to the 2011 European Association of Centres of Medical Ethics (EACME) annual conference, draws on both national legislation in European states and the Conventions of the Council of Europe as well as EU instruments such the Opinions of the European Group on Ethics in Science and New Technologies (EGE) and the Charter of Fundamental Rights to examine the current state of national and regional diversity in approaches to key bioethics issues and examines its evolution with reference to debates surrounding the development of key pieces of EU legislation and Council of Europe policy with bioethical implications. The relationship between the EU's genesis as a primarily economic and commercial governance entity--with its accompanying emphasis on the harmonization of technical standards--and its approach to diversity in national bioethical perspectives is also examined. Conclusions are drawn as to the relative success and desirability of the European consensus process in bioethics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
